Monitoring of the West Nile virus epidemic in Spain between 2010 and 2011.
West Nile virus (WNV) is a mosquito-transmitted flavivirus recognized as an emerging and re-emerging pathogen in different countries. This study describes the monitoring of the first WNV epidemic in Spain between 2010 and 2011. Between September and December 2010, 36 outbreaks of WNV in horses were reported in three different provinces of Andalusia (southern Spain), with no apparent spread outside this area. The temporal distribution and the clinical signs observed during the WNV epidemic in Spain were, in general, similar to those reported in Europe and in the Mediterranean Basin. Morbidity, mortality and fatality rate in the affected herds were 4.6, 1.4 and 35.3%, respectively. Thirty-six of 75 (47.4%) suspected herds investigated presented at least one IgM seropositive animal. The individual seroprevalence in unvaccinated animals from the infected holdings was 51.7%. RNA WNV lineage 1 virus was confirmed from blood and cerebrospinal fluid samples in a lethally infected horse. The entomological survey showed that the most abundant mosquito species detected in the affected area was Culex pipiens. A cross-sectional study was carried out in non-suspected herds between April 2010 and February 2011 in the affected area. The individual seroprevalence was 11.0%, and six of the 38 herds sampled (15.8%) presented at least one seropositive animal. The results showed active WNV circulation several months before the first outbreak was reported in horses. The seropositivity found in municipalities where clinical cases were not reported indicates a higher geographical dissemination of the virus. Significantly higher seroprevalences were detected in areas close to Morocco. Furthermore, 90 wild ruminants were tested for the presence of antibodies against WNV, but the results were all negative.
Departamento de Sanidad Animal. Facultad de Veterinaria, UCO, Campus Universitarios de Rabanales, Córdoba, Spain. nacho.garcia@uco.es
I
I
García-Bocanegra
J A
JA
Jaén-Téllez
S
S
Napp
A
A
Arenas-Montes
M
M
Fernández-Morente
V
V
Fernández-Molera
A
A
Arenas
D000818:Animals; D000914:Antibodies, Viral; D003430:Cross-Sectional Studies; D003465:Culex; D004797:Enzyme-Linked Immunosorbent Assay / Q000662:veterinary; D058872:Epidemics / Q000662:veterinary*; D005260:Female; D006734:Horse Diseases / Q000453:epidemiology / Q000821:virology*; D006736:Horses; D008297:Male; D012621:Seasons; D016036:Seroepidemiologic Studies; D013030:Spain / Q000453:epidemiology; D013997:Time Factors; D010948:Viral Plaque Assay; D014765:Viral Vaccines / Q000276:immunology; D014901:West Nile Fever / Q000453:epidemiology / Q000517:prevention & control / Q000662:veterinary* / Q000821:virology; D014902:West Nile virus / Q000235:genetics / Q000302:isolation & purification
D000914:Antibodies, Viral; D014765:Viral Vaccines